Grabbed some at 14.00 with beer money.. just for fun.

Seems strange a CEO of a huge company has a gmail address and phone number in BC Canada when this Compnay is in IL and emails of people working there end in @na.com Not adding up. but good luck to all still in. Got out end of day with tiny profit. But watching.

placed bet but got out end of day with small gain. Presedent listed on OTCmarkets site has a gmail address ? and phone number out of Canada ? North American is in IL, something not adding up. But time will tell.

Good news, but still cloud over this because, all this does is require them to take another look, they still can reissue same MDOs at the end of it all. Not sure if any other companies have been cleared for flavored products.. Maybe Kaival will be the trend setter.

Did my part added 30K shares to my stash.

Some post on twitter about upcoming announcements
see my previous post

Guess its fake. sorry for posting

Take it for what its worth https://twitter.com/mineral_rite/status/1560649717201223681

Would like to see the agreement terms.

Is that a guess? Or fact. What’s the catalyst today? Short cover day ? I don’t see any news

I would say , the run to 36. ( 3.60 area pre split) was due to a number of things.. KAVL was a revers merger play. Which ran to about .80 pre split then settled around .30 for a bit. Then sales numbers started coming in, and they were doing very well, so it started up again, then they were forecasting 400mil in sales for the year, and a up list to Nasdaq. ( this was before all the FDA stuff, so around then is when it ran to 3.60, then pulled back a bit to around the 2.00 area.( again pre split) Don't recall the exact timeline, but one of the Q's numbers were not very good because they were pulling all of their product to rebrand it to be proactive about FDA guidance and trying to be proactive about this FDA thing, then to up list to the Nas, they did a 1 for 12 reverse split, which didn't sit well, then due to the up coming FDA dead line, many of their distributors started holding off buying more product. Also covid was mixed in there, which also hurt their numbers.
Finally the MDO for all but Tabaco flavor was the final blow.
That's it in a nutshell.

Anyone have any idea where all this volume is coming from.
KAVL only has around 30 mil OS and float is probably half that.
How does this trade 100mil. Not complaining, just don't get it.

Hopefully they have made some progress on sales over seas, to offset the
BS here in the US..

It was at a high of around 4$ a share before the split to get share price up for up-list to Nasdaq.. so about 45 post split, yes.

You and I have been here since the pre split .20 days..
I am wondering how this thing trades the volume it does if the float is only 16mil or so ? Just wondering you thoughts. Seems strange

16 mill in float.. we traded the float almost 4 times today ? crazy.

How The F do we trade 53Million shares.

7.92 before forward Split. .79 would be post split equivalent. But still sucks

Kind of a long read, but interesting if you have not read it, and care about what is happening here. https://www.khlaw.com/sites/default/files/2021-10/Bidi_Motion_to_Stay_and_Addendum-11th_Circuit_Court_of_Appeals.pdf

Especially section IV. No Requirement For Long-Term Studies page 7 which up until Sept, the FDA said there was no need for, but then seemed to base their MDO for Kaival on this one point.

And which is seems Kaival has just answered with this new PR>

Well, at least they have not given up. Not sure what more the FDA will
want at this point. One of the things the FDA wanted was a study, ( even though previously they said they didn't need a study, thus it was not pursued) now the have it. So guess we will see what they say next. Maybe now we get approval.

Not sure if this is new or not.
https://wholesale.bidivapor.co.uk/

agreed ..

While this is good news, (a few of us noticed this last week actually and posted about it) its not the news we need to get this back were it could be.
We need FDA approval.
Until then, its still unfortunately, in a holding pattern.
I cant imagine any retailer taking the risk of buying a bunch of flavored product to only not be able to sell if if the FDA issues a MDO on the flavored stuff again.

He posted a link to the Tobacco products marketing order page.

Open up the MDO link to open the Market Denial Orders CSV there are 4 MDOs that appear with comments.. ( see below)
as of 10/22 FDA issued a stay for the MDO issued to BIDI. That MDO covered all the flavored products including menthol. I would assume eventually, the will split off Menthol and will allow it, but will reissue the MDO for the flavors but for now, its no longer under a MDO.
Time will tell. I doubt there will be any news release about it, until its a "Market Granted Order".. but its a step in the right direction anyway

My Vape Order Inc. 9/8/2021 FDA is reviewing this MDO pursuant to 21 C.F.R. § 10.75.  On October 18, 2021, the Agency issued a stay for this MDO pending its review.
Bidi Vapor 9/7/2021 FDA is reviewing this MDO pursuant to 21 C.F.R. § 10.75.  On October 22, 2021, the Agency issued a stay for this MDO pending its review.
Wages & White Lion Investments dba Triton Distribution 9/14/2021 On October 14, 2021, the United States Court of Appeals for the Fifth Circuit issued a temporary administrative stay of Triton’s MDO pending further order of the court.
Gripum LLC 9/8/2021 On October 19, 2021, the United States Court of Appeals for the Seventh Circuit issued a temporary administrative stay of Gripum's MDO pending further order of the court.

Ya. That too !

So were all the others out there.. But now, due to FDA we can have 2 kinds.. Tabaco and menthol. So I have to agree with his statement, that if that the only choices, the people will migrate to those. They could potentially market a couple options of the menthol version. Like for example a lightly mentholated version vs a normal. I mean, those of us that smoke have to options. menthol or not.. so while the flavored was a new option, It no longer will be for anyone. Main thing is to get thru this approval BS.. F'n FDA

HI, I believe that was only for the Arctic flavor ( Menthol ) They are appealing it because standard tobacco and menthol were supposed to be allowed, while all other "flavors" are being shut down

Due to increased pressure from, among others, tobacco control and public health groups, members of Congress, academic institutions, family advocacy organizations and attorneys general, we believe that the FDA has used the September 9, 2021 PMTA deadline to effectively “ban” flavored ENDS by denying nearly all pending PMTAs for such products. As of September 10, 2021, the FDA announced that it has taken action on over 93% of applications and issued Marketing Denial Orders (“MDOs”) for more than 992,000 flavored ENDS products, while issuing zero marketing authorizations. Unfortunately, despite submitting a comprehensive PMTA and continuing to develop robust and reliable product-specific scientific evidence demonstrating the public health benefit of its flavored ENDS products, Bidi, along with nearly every other company in the ENDS industry, received a MDO for its non-tobacco flavored BIDI® Sticks, including its Arctic (menthol) BIDI® Stick, which the FDA mischaracterized as “flavored”. However, because its Arctic BIDI® Stick is menthol, Bidi believes its menthol BIDI® Stick is not subject to the MDO. This position is aligned with the FDA’s public statements and press releases stating that tobacco and menthol ENDS are not deemed flavored products subject to the MDOs. Accordingly, along with the Classic (tobacco) BIDI® Stick, Bidi intends to continue to manufacture and market its Arctic (menthol) BIDI® Stick for distribution by us.

Historically, substantially all of our revenues were derived from sales of flavored BIDI® Sticks, including the Arctic (menthol) BIDI® Stick, sales of which constituted approximately 15.2% and 18.5%, respectively, of our total sales of BIDI® Sticks for the three and nine months ended July 31, 2021. Generally, substantially all of the ENDS industry revenue is derived from the sales of flavored products.

Following the issuance of the MDOs, nearly all manufacturers, not only BIDI, will be limited to manufacturing and selling only tobacco and menthol ENDS products. Accordingly, we believe that consumers are likely to modify their purchases to shift to products that are available and, thus, that a substantial amount of our revenue that had previously been generated from sales of flavored BIDI® Sticks (other than Arctic) may be replaced through sales of the Classic (tobacco) and Arctic (menthol) BIDI® Sticks, given that consumers will only be able to purchase, on a legal basis, non-flavored ENDS products. Accordingly, we believe revenues for tobacco and menthol ENDS products will restore some or all of the revenue we derived from the sale of flavored products. Moreover, based on sales and consumer data, we believe that our consumers are loyal to the Bidi brand and BIDI® Sticks and that they thus are likely to continue to purchase our Classic (tobacco) and Arctic (menthol) BIDI® Sticks in lieu of the flavored BIDI® Sticks they may have bought in the past.

HI, I believe that was only for the Arctic flavor ( Menthol ) They are appealing it because standard tobacco and menthol were supposed to be allowed, while all other "flavors" are being shut down..

I see short term set backs for long term success.
They were projecting 400 mil based on the market at that time, and they were on track. Then with the FDA crap and changes they saw coming, they decided last fall to make changes to the way the market the product so they could ensure they would be able to continue to sell after the FDA decision.
That set them back last fall. But set them up for success longer term. They made sure they were above and beyond the FDA's base line. They also changed the way the sell some of their product. They stated that initially they were looking to make the pouch with synthetic nicotine, but then again saw the writing on the wall with the FDA probably going to classify it as drug, and the issues that would cause. So held up on that, until things were clearer.
So what some see as inaction, I guess I see as looking forward to what is coming and making sure they are in a position to still be around and not wasting money on something they wont be able to market. This FDA thing really f'd up a lot of companies, Kaval is still here. Time will tell.

that would be a start anyway.

From the disclaimer: Argus Research receives no part of its compensation in the form of stock or other securities issued by the company discussed in this report, and has no long equity position or short sale position in the company’s stock. Argus Research is not involved in underwriting securities for the subject company, and will receive no proceeds or other financial benefit from any securities offering by the company. Argus Research; its officers, directors, and affiliates; and the author of this report have no finan- cial interest in, or affiliation with, the subject firm. The report is disseminated primarily in electronic form and is made available at approximately the same time to all eligible recipients.

The conversion price per share is $9.1188, so betting they want this higher at some point ! lol

LOL volatility trading pause.. ?? lol good grief..

down side to Nasdaq.. you can short the stock. Up side is they will have to also cover ..at some point.

Thanks.. !

Ya, that whole thing seemed kinda suspect to me. Not sure why someone would call telling you to buy as some great news is coming. Not from the company anyway. Seems like that could get you in trouble quick. LOL. idk. well see.

Ya, that whole thing seemed kinda suspect to me. Not sure why someone would call telling you to buy as some great news is coming. Not from the company anyway. Seems like that could get you in trouble quick. LOL. idk. well see.

I guess I don't get why people keep saying the CEO is incompetent. He is doing what he has to do. He has and is continuing to do what he said he would. The rest is all hearsay and people speculating and what might happen . And that's what gets ya in trouble. I feel they have accomplished a lot. He has us well positioned for when the new regs kick in be redoing the packaging get paperwork filed. We moved to the NAS, were selling product, and moving forward. The only thing that has potentially failed was the 400mil guidance. But even that I can forgive as things have changed in the market since then that they could not foresee. But the year is not up yet. Well see what happens next Q. good luck to ya !

I get why people are down on this at the moment, but the company didn't promise you anything. This ran from pennies to dollars, if you didn't cash out, that's not their fault. They are building a business. These are the growing pains. They are moving forward. Maybe not at the pace you would like to see, but that's how things go when real businesses grow. Share price will follow. The CEO bought a ton of shares on the 2.50 range. I suspect he doesn't want to just throw that money down the toilet, and would like to see this higher as well. But I would rather see him worrying about growth and building the business long term, then worrying about how to prop up the share price short term. but that's me.. good luck to ya

To me, the whole purpose of being in a capitol market is to raise $$ for
investment and expansion if needed. Nothing yet has been offered. Its a preregistration. So if and when they might need to raise capitol, they can. If used properly, in the long run we benefit if Kavl grows and expands. Seems to be a lot of short term OTC thinking here still.